ER ER (Erythromycin Delayed-Release 250 mg (erythromycin base))
Pill with imprint ER ER is Pink / Red, Capsule-shape and has been identified as Erythromycin Delayed-Release 250 mg (erythromycin base). It is supplied by Arbor Pharmaceuticals, Inc.
Erythromycin is used in the treatment of bronchitis; bacterial endocarditis prevention; bartonellosis; bowel preparation; otitis media and belongs to the drug class macrolides. There is no proven risk in humans during pregnancy. Erythromycin 250 mg (erythromycin base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for ER ER
Erythromycin Delayed-Release
- Imprint
- ER ER
- Strength
- 250 mg (erythromycin base)
- Color
- Pink / Red
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Macrolides
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Arbor Pharmaceuticals, Inc.
- Inactive Ingredients
-
cellulose powdered,
citric acid monohydrate,
D&C Red No. 30,
D&C Yellow No. 10,
magnesium stearate,
FD&C Blue No. 1,
FD&C Red No. 3,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 24338-0120 | |
| 54569-2281 | A-S Medication Solutions, LLC (repackager) |
Related images for "ER ER"
More about erythromycin
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (58)
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: macrolides
Patient resources
- Drug Information
- Erythromycin (Advanced Reading)
- Erythromycin Intravenous (Advanced Reading)
- Erythromycin Delayed-Release Tablets and Capsules
- Erythromycin Tablets
Other brands
Erythrocin, Ilosone, E.E.S. Granules, Ery-Tab, ... +4 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.